C‐Reactive Protein (CRP)‐Lowering Agents
Open accessThe DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
C‐reactive protein (CRP) plays a role in the pathogenesis of cardiovascular disease. It is a marker and predictor of cardiovascular disease. CRP possesses numerous cardiovascular effects (clotting, generation of oxygen radicals, increase in the expression of adhesion molecules and plasminogen activator inhibitor‐1, plaque destabilization) that could result in cardiovascular disease. This review describes the effects of various cardiovascular drugs on the levels of CRP in health and disease. Cyclooxygenase inhibitors (aspirin, rofecoxib, celecoxib), platelet aggregation inhibitors (clopidogrel, abciximab), lipid lowering agents (statins, ezetimibe, fenofibrate, niacin, diets), β‐adrenoreceptor antagonists and antioxidants (vitamin E), as well as angiotensin converting enzyme (ACE) inhibitors (ramipril, captopril, fosinopril), reduce serum levels of CRP; while enalapril and trandolapril have not been shown to have the same effect. Angiotensin receptor blockers (ARBs) (valsartan, irbesartan, olmesartan, telmisartan) markedly reduce serum levels of CRP. The findings with other ARBs (losartan and candesartan) were inconsistent. Antidiabetic agents (rosiglitazone and pioglitazone) reduce CRP levels, while insulin is ineffective. Calcium channel antagonists have variable effects on CRP levels. Hydrochlorothiazide and oral estrogen do not affect CRP. The CRP‐lowering effect of statins is more pronounced than their lipid lowering effect and is not dependent on their hypolipemic activity. The effect of atorvastatin on CRP seems to be dose‐dependent. CRP‐lowering effect of statins is likely to contribute to the favorable outcome of statin therapy. The data suggest that lipid lowering agents, ACE inhibitors, ARBs, antidiabetic agents, antiinflammatory and antiplatelet agents, vitamin E, and β‐adrenoreceptor antagonists lower serum or plasma levels of CRP, while vitamin C, oral estrogen and hydrochlorothiazide do not affect CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,296
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,013
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
Cermak, J., Key, N., Bach, R., Balla, J., Jacob, H., & Vercellotti, G. (1993) · Blood · doi:10.1182/blood.v82.2.513.513 · Cited by 839
C-Reactive Protein as a Cardiovascular Risk Factor: More Than an Epiphenomenon?
Lagrand, W. K., Visser, C. A., Hermens, W. T., Niessen, H. W. M., Verheugt, F. W. A., Wolbink, G.-J., & Hack, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.1.96 · Cited by 833
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B., & Devaraj, S. (2001) · Circulation · doi:10.1161/01.cir.103.15.1933 · Cited by 730
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., Muche, R., Brenner, H., & Koenig, W. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1835 · Cited by 688
Ballantyne, C. M., Houri, J., Notarbartolo, A., Melani, L., Lipka, L. J., Suresh, R., Sun, S., LeBeaut, A. P., Sager, P. T., & Veltri, E. P. (2003) · Circulation · doi:10.1161/01.cir.0000068312.21969.c8 · Cited by 687
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Body mass index, diabetes, and C-reactive protein among U.S. adults.
Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 644
Jenkins, D. J. A. (2003) · JAMA · doi:10.1001/jama.290.4.502 · Cited by 620
Vascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586
Ikonomidis, I., Andreotti, F., Economou, E., Stefanadis, C., Toutouzas, P., & Nihoyannopoulos, P. (1999) · Circulation · doi:10.1161/01.cir.100.8.793 · Cited by 573
Gagné, C., Bays, H. E., Weiss, S. R., Mata, P., Quinto, K., Melino, M., Cho, M., Musliner, T. A., & Gumbiner, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02774-1 · Cited by 495
Ridker, P. M., Rifai, N., & Lowenthal, S. P. (2001) · Circulation · doi:10.1161/01.cir.103.9.1191 · Cited by 415
Fliser, D., Buchholz, K., & Haller, H. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 404
Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E
Prasad, K., & Kalra, J. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90102-f · Cited by 383
Self-citationInduction of inflammatory cytokine release from cultured human monocytes by C-reactive protein
Ballou, S. P., & Lozanski, G. (1992) · Cytokine · doi:10.1016/1043-4666(92)90079-7 · Cited by 368
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease
Chenevard, R., Hürlimann, D., Béchir, M., Enseleit, F., Spieker, L., Hermann, M., Riesen, W., Gay, S., Gay, R. E., Neidhart, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000051361.69808.3a · Cited by 358
Plenge, J. K., Hernandez, T. L., Weil, K. M., Poirier, P., Grunwald, G. K., Marcovina, S. M., & Eckel, R. H. (2002) · Circulation · doi:10.1161/01.cir.0000029743.68247.31 · Cited by 354
Upritchard, J. E., Sutherland, W. H., & Mann, J. I. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.733 · Cited by 353
Isoprenoids as mediators of the biological effects of statins
Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216421 · Cited by 352
Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
Rohde, L. E. P., Hennekens, C. H., & Ridker, P. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00491-9 · Cited by 349
Buffon, A., Liuzzo, G., Biasucci, L. M., Pasqualetti, P., Ramazzotti, V., Rebuzzi, A. G., Crea, F., & Maseri, A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00348-4 · Cited by 344
Regulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Bhakdi, S., Torzewski, M., Klouche, M., & Hemmes, M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2348 · Cited by 326
Walsh, B. W., Paul, S., Wild, R. A., Dean, R. A., Tracy, R. P., Cox, D. A., & Anderson, P. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6326 · Cited by 326
C-Reactive Protein and Outcome After Ischemic Stroke
Muir, K. W., Weir, C. J., Alwan, W., Squire, I. B., & Lees, K. R. (1999) · Stroke · doi:10.1161/01.str.30.5.981 · Cited by 317
THE LIVER AS THE SITE OF C-REACTIVE PROTEIN FORMATION
Hurlimann, J., Thorbecke, G. J., & Hochwald, G. M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.2.365 · Cited by 311
Van Heek, M., France, C. F., Compton, D. S., Mcleod, R. L., Yumibe, N. P., Alton, K. B., Sybertz, E. J., & Davis, H. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36992-7 · Cited by 305
Fischer, C. P., Hiscock, N. J., Penkowa, M., Basu, S., Vessby, B., Kallner, A., Sjöberg, L., & Pedersen, B. K. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066779 · Cited by 293
Prasad, K. (1999) · Circulation · doi:10.1161/01.cir.99.10.1355 · Cited by 290
Self-citationCOMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES*
Volanakis, J. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22140.x · Cited by 278
Vehkavaara, S., Silveira, A., Hakala-Ala-Pietilä, T., Virkamäki, A., Hovatta, O., Hamsten, A., Taskinen, M.-R., & Yki-Järvinen, H. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615643 · Cited by 270
Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function
Webster, R. O., Hong, S. R., Johnston, R. B., & Henson, P. M. (1980) · Immunopharmacology · doi:10.1016/0162-3109(80)90050-8 · Cited by 261
Radioimmunoassay of human C-reactive protein and levels in normal sera.
Claus, D. R., Osmand, A. P., & Gewurz, H. (1976) · PubMed · Cited by 251
Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines
Mackiewicz, A., Speroff, T., Ganapathi, M. K., & Kushner, I. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3032 · Cited by 240
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.065 · Cited by 239
Kashyap, M. L., McGovern, M. E., Berra, K., Guyton, J. R., Kwiterovich, P. O., Harper, W. L., Toth, P. D., Favrot, L. K., Kerzner, B., Nash, S. D., et al. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02338-4 · Cited by 235
Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed
Prasad, K. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.012 · Cited by 232
Self-citationDevaraj, S., & Jialal, I. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00420-2 · Cited by 227
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
Koh, K. K., Ahn, J. Y., Han, S. H., Kim, D. S., Jin, D. K., Kim, H. S., Shin, M.-S., Ahn, T. H., Choi, I. S., & Shin, E. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00846-5 · Cited by 225
Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation
Walter, D. H., Fichtlscherer, S., Sellwig, M., Auch-Schwelk, W., Schächinger, V., & Zeiher, A. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01193-1 · Cited by 222
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women
Cushman, M., Meilahn, E. N., Psaty, B. M., Kuller, L. H., Dobs, A. S., & Tracy, R. P. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.893 · Cited by 218
Rosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients
Raji, A., Seely, E. W., Bekins, S. A., Williams, G. H., & Simonson, D. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.172 · Cited by 215
C-REACTIVE PROTEIN, INFLAMMATION, AND CORONARY RISK
Morrow, D. A., & Ridker, P. M. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70211-x · Cited by 212
Effect of statins on C-reactive protein in patients with coronary artery disease
Strandberg, T. E., Vanhanen, H., & Tikkanen, M. J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76154-7 · Cited by 209
Dandona, P., Kumar, V., Aljada, A., Ghanim, H., Syed, T., Hofmayer, D., Mohanty, P., Tripathy, D., & Garg, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021836 · Cited by 207
Intensive Statin Therapy — A Sea Change in Cardiovascular Prevention
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejme048061 · Cited by 197
Lincoff, A. M., Kereiakes, D. J., Mascelli, M. A., Deckelbaum, L. I., Barnathan, E. S., Patel, K. K., Frederick, B., Nakada, M. T., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.104.2.163 · Cited by 196
Feldman, M., Jialal, I., Devaraj, S., & Cryer, B. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01289-x · Cited by 181
Zanger, D., Yang, B. K., Ardans, J., Waclawiw, M. A., Csako, G., Wahl, L. M., & Cannon, R. O. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00952-9 · Cited by 170
van de Ree, M. A., Huisman, M. V., Princen, H. M. G., Meinders, A. E., & Kluft, C. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00316-7 · Cited by 159
Hall, W. L., Vafeiadou, K., Hallund, J., Bügel, S., Koebnick, C., Reimann, M., Ferrari, M., Branca, F., Talbot, D. C. S., Dadd, T., et al. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1260 · Cited by 159
Chan, D. C., Watts, G. F., Barrett, P. H. R., Beilin, L. J., & Mori, T. A. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.6.877 · Cited by 150
Malik, J. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00382-0 · Cited by 149
Walsh, B. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.214 · Cited by 143
Di Napoli, M., & Papa, F. (2003) · Stroke · doi:10.1161/01.str.0000099124.84425.bb · Cited by 122
Ishikawa, T., Hatakeyama, K., Imamura, T., Date, H., Shibata, Y., Hikichi, Y., Asada, Y., & Eto, T. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03156-9 · Cited by 113
Zairis, M. N., Ambrose, J. A., Manousakis, S. J., Stefanidis, A. S., Papadaki, O. A., Bilianou, H. I., DeVoe, M. C., Fakiolas, C. N., Pissimissis, E. G., Olympios, C. D., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02267-2 · Cited by 113
Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., & Asada, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.051 · Cited by 112
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease
Himmelfarb, J., Kane, J., Mcmonagle, E., Zaltas, E., Bobzin, S., Boddupalli, S., Phinney, S., & Miller, G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00151.x · Cited by 111
Fredrikson, G. N., Hedblad, B., Nilsson, J., Alm, R., Berglund, G. L., & Nilsson, J. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.010 · Cited by 109
Woodward, M., Lowe, G. D. O., Francis, L., Rumley, A., & Cobbe, S. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.01017.x · Cited by 107
Fumeron, C., Nguyen-Khoa, T., Saltiel, C., Kebede, M., Buisson, C., Drüeke, T. B., Lacour, B., & Massy, Z. A. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh928 · Cited by 107
Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension
Dohi, Y., Ohashi, M., Sugiyama, M., Takase, H., Sato, K., & Ueda, R. (2003) · Hypertension Research · doi:10.1291/hypres.26.691 · Cited by 106
Jenkins, N. P., Keevil, B. G., Hutchinson, I. V., & Brooks, N. H. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01115-9 · Cited by 106
Timing of Antioxidant Vitamin Ingestion Alters Postprandial Proatherogenic Serum Markers
Carroll, M. F., & Schade, D. S. (2003) · Circulation · doi:10.1161/01.cir.0000074221.68903.77 · Cited by 104
Effect of oxygen free radicals on cardiovascular function at organ and cellular levels
Prasad, K., Kalra, J., Chan, W. P., & Chaudhary, A. K. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90396-7 · Cited by 103
Self-citationLacut, K., Oger, E., Gal, G. L., Blouch, M., Abgrall, J., Kerlan, V., Scarabin, P., & Mottier, D. (2003) · PubMed · doi:10.1267/thro03010124 · Cited by 101
Tamoxifen and Cardiac Risk Factors in Healthy Women: Suggestion of an Anti-inflammatory Effect
Cushman, M., Costantino, J. P., Tracy, R. P., Song, K., Buckley, L. M., Roberts, J. D., & Krag, D. N. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.2.255 · Cited by 100
Prasad, K., Kalra, J., Chaudhary, A. K., & Debnath, D. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80276-5 · Cited by 99
Self-citationRuilope, L. M., Malacco, E., Khder, Y., Kandra, A., Bönner, G., & Heintz, D. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.05.006 · Cited by 96
Undas, A., Celinska-Löwenhoff, M., Domagala, T. B., Iwaniec, T., Dropinski, J., Löwenhoff, T., & Szczeklik, A. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0067 · Cited by 90
High-Intensity Statin Treatment for Coronary Heart Disease
Sacks, F. M. (2004) · JAMA · doi:10.1001/jama.291.9.1132 · Cited by 89
Takeda, T., Hoshida, S., Nishino, M., Tanouchi, J., Otsu, K., & Hori, M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00158-8 · Cited by 89
Role of C-Reactive Protein in Cardiovascular Disease
Backes, J. M., Howard, P. A., & Moriarty, P. M. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d203 · Cited by 83
Short-term effects of atorvastatin on C-reactive protein
Riesen, W., Engler, H., Risch, M., Korte, W., & Noseda, G. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2967 · Cited by 81
Oger, E., Le Gal, G., Blouch, M.-T., Abgrall, J.-F., Kerlan, V., Scarabin, P.-Y., Mottier, D., Lacut, K., & and the SARAH investigators (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613608 · Cited by 77
Jm, V. D. A., Bredie, S. J. H., Sh, D., van Tits, L. J. H., Stalenhoef, A. F. H., & van Leusen, R. (2003) · Journal of Nephrology · doi:10.1093/joneph/16.2.238 · Cited by 77
Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of probucol
Prasad, K., Kalra, J., & Lee, P. (1994) · International Journal of Angiology · doi:10.1007/bf02014924 · Cited by 76
Self-citationBeattie, M. S., Shlipak, M. G., Liu, H., Browner, W. S., Schiller, N. B., & Whooley, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000044387.23578.e9 · Cited by 73
Effects of hormone therapyon C-reactive protein and IL-6 in postmenopausal women: a review article
Lakoski, S. G., & Herrington, D. M. (2005) · Climacteric · doi:10.1080/13697130500345109 · Cited by 72
Žegura, B., Keber, I., Šebeštjen, M., & Köenig, W. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00088-1 · Cited by 71
Lu, Q., Björkhem, I., Wretlind, B., Diczfalusy, U., Henriksson, P., & Freyschuss, A. (2005) · Clinical Science · doi:10.1042/cs20040291 · Cited by 70
Prasad, A., Koh, K. K., Schenke, W. H., Mincemoyer, R., Csákó, G., Fleischer, T. A., Brown, M., Selvaggi, T. A., & Quyyumi, A. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116699 · Cited by 68
Pahor, M., Franse, L. V., Deitcher, S. R., Cushman, W. C., Johnson, K. C., Shorr, R. I., Kottke-Marchant, K., Tracy, R. P., Somes, G. W., & Applegate, W. B. (2002) · Circulation · doi:10.1161/hc0402.102929 · Cited by 67
Effects of fenofibrate on lipid parameters in obese rhesus monkeys
Winegar, D. A., Brown, P. J., Wilkison, W. O., Lewis, M. C., Ott, R. J., Tong, W. Q., Brown, H. R., Lehmann, J. M., Kliewer, S. A., Plunket, K. D., et al. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32207-0 · Cited by 67
Yasunari, K., Maeda, K., Nakamura, M., Watanabe, T., Yoshikawa, J., & Asada, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.029 · Cited by 66
C-Reactive Protein and Cardiovascular Diseases
Prasad, K. (2003) · International Journal of Angiology · doi:10.1007/s00547-003-1018-y · Cited by 66
Self-citationKoulouris, S. N., Symeonides, P., Triantafyllou, K. A., Ioannidis, G., Karabinos, I. K., Katostaras, T., El-Ali, M., Theodoridis, T., Vratsista, E., Thalassinos, N., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.092 · Cited by 64
Costa, A., Casamitjana, R., Casals, E., Álvarez, L., Morales, J., Masramón, X., Hernández, G., Gomis, R., & Conget, I. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00993.x · Cited by 62
Rouis, M., Nigon, F., & Chapman, M. J. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80773-3 · Cited by 62
Moser, M., & Frishman, W. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00424-x · Cited by 61
C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils
Prasad, K. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900308 · Cited by 57
Self-citationYildiz, M. F., Kumru, S., Godekmerdan, A., & Kutlu, S. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.05.005 · Cited by 56
Smith, K. S., Lee, C., Ridlington, J. W., Leonard, S. W., Devaraj, S., & Traber, M. G. (2003) · Lipids · doi:10.1007/s11745-003-1130-9 · Cited by 56
Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values
Tsimihodimos, V., Kostoula, A., Kakafika, A. I., Bairaktari, E. T., Tselepis, A. D., Mikhailidis, D. P., & Elisaf, M. (2004) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840400900i105 · Cited by 55
Schram, M. T., van Ittersum, F. J., de Man, A., van Dijk, R. A. J. M., Schalkwijk, C., IJzerman, R. G., Twisk, J. W. R., & Stehouwer, C. D. A. (2005) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001812 · Cited by 53
Anti-Inflammatory and Anticoagulant Effects of Pravastatin in Patients With Type 2 Diabetes
Sommeijer, D. W., Macgillavry, M. R., Meijers, J. C. M., van Zanten, A. P., Reitsma, P. H., & Cate, H. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.468 · Cited by 53
Blann, A. D., Gurney, D. A., Hughes, E. A., Buggins, P., Silverman, S., & Lip, G. Y. H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01597-1 · Cited by 53
D'Anna, R., Baviera, G., Corrado, F., Cancellieri, F., Crisafulli, A., & Squadrito, F. (2005) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.0001-6349.2005.00661.x · Cited by 52
Is there increased sympathetic activity in patients with hypertrophic cardiomyopathy?
Lü, F., Slade, A., Prasad, K., Malík, M., McKenna, W. J., & Camm, A. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80025-c · Cited by 51
Self-citationPrasad, K., & Lee, P. (2003) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840300800i109 · Cited by 48
Self-citationJoynt, K. E., Gattis, W. A., Hasselblad, V., Fuzaylov, S. Y., Serebruany, V. L., Gurbel, P. A., Gaulden, L. H., Felker, G. M., Whellan, D. J., & O’Connor, C. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.010 · Cited by 48
Ishikawa, T., Imamura, T., Hatakeyama, K., Date, H., Nagoshi, T., Kawamoto, R., Matsuyama, A., Asada, Y., & Eto, T. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.11.030 · Cited by 47
Monakier, D., Mates, M., Klutstein, M. W., Balkin, J., Rudensky, B., Meerkin, D., & Tzivoni, D. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1610 · Cited by 47
Effects of Transdermal Estrogen Replacement Therapy on Cardiovascular Risk Factors
Menon, D. V., & Vongpatanasin, W. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00005 · Cited by 46
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors
Keber, I., Žegura, B., Simčič, S., Mijovski, M. B., Migaud-Fressart, M., Stegnar, M., & Šebeštjen, M. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0250 · Cited by 45
Post, M. S., Stehouwer, C. D. A., van Baal, W. M., Mijatovic, V., Schalkwijk, C. G., Kenemans, P., & van der Mooren, M. J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613263 · Cited by 44
Effect of atorvastatin and pravastatin on serum C-reactive protein
Kent, S. M., Flaherty, P. J., Coyle, L. C., Markwood, T. T., & Taylor, A. J. (2003) · American Heart Journal · doi:10.1067/mhj.2003.34 · Cited by 43
Bays, H. E., Stein, E. A., Shah, A. K., Maccubbin, D., Mitchel, Y., & Mercuri, M. F. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02658-9 · Cited by 39
Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes
Murphy, R. T., Foley, J. B., Tome, M., Mulvihill, N. T., Murphy, A., McCarroll, N. A., Crean, P., & Walsh, M. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.018 · Cited by 39
Li, C., Sun, B., Lim, S. W., Song, J. C., Kang, S., Kim, Y. S., Kang, D., Cha, J. H., Kim, J., & Yang, C. W. (2005) · Transplantation · doi:10.1097/01.tp.0000155305.49439.4c · Cited by 36
Mitrović, V. L., Klein, H. H., Krekel, N., Kreuzer, J., Fichtlscherer, S., Schirmer, A., Paar, W. D., & Hamm, C. W. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0222-5 · Cited by 33
Tsikouris, J. P., Suarez, J. A., Simoni, J. S., et al. (2004) · PubMed · Cited by 32
Oubiña, M. P., Heras, N. D. L., Cediel, E., Sanz‐Rosa, D., Aragoncillo, P., Díaz-Jullien, C., Hernández, G., Lahera, V., & Cachofeiro, V. (2003) · Clinical Science · doi:10.1042/cs20030127 · Cited by 31
Niacin extended-release/ lovastatin: combination therapy for lipid disorders
Moon, Y. S., & Kashyap, M. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1763 · Cited by 28
Doo, Y., Kim, D. M., Oh, D., Ryu, K. H., Rhim, C., & Lee, Y. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01693-9 · Cited by 22
Yeşilbursa, D., Serdar, A., Saltan, Y., Serdar, Z., Heper, Y., Güçlü, S., & Cordan, J. (2005) · PubMed · Cited by 22
Lee, P., & Prasad, K. (2003) · International Journal of Angiology · doi:10.1007/s00547-003-0976-4 · Cited by 18
Self-citationÇoban, E., Özdoğan, M., Yazicioglu, G., & Sarı, R. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00428.x · Cited by 17
Avilés-Santa, L. M., Salinas, K., ADAMS-HUET, B. A., & Raskin, P. (2006) · Journal of Investigative Medicine · doi:10.2310/6650.2005.05012 · Cited by 16
Yamada, S., Yanagawa, T., Sasamoto, K., Araki, A., Miyao, M., & Yamanouchi, T. (2005) · Metabolism · doi:10.1016/j.metabol.2005.07.017 · Cited by 16
Effect of Losartan on Plasma C-Reactive Protein in Type 2 Diabetic Patients With Microabluminuria
Tan, K. C. B., Chow, W.-S., Wong, Y., Shiu, S. W. M., & Tam, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1254 · Cited by 14
Çoban, E., & Sarı, R. (2004) · Endocrine Research · doi:10.1081/erc-200033541 · Cited by 13
Atar, İ., Gülmez, Ö., Atar, A., Bozbaş, H., Yı́ldı́rı́r, A., Özin, B., Korkmaz, M. E., & Müderrisoğlu, H. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280509 · Cited by 10
Biasucci, L. M., Lombardi, M., Piro, M., Giannuario, G. D., Liuzzo, G., & Crea, F. (2005) · Heart · doi:10.1136/hrt.2004.036509 · Cited by 10
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
O’Connor, M.-F., Bower, J. E., Cho, H. J., Creswell, J. D., Dimitrov, S., Hamby, M. E., Hoyt, M. A., Martin, J. L., Robles, T. F., Sloan, E. K., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.005 · Cited by 500
Simanek, A. M., Dowd, J. B., Pawelec, G., Melzer, D., Dutta, A., & Aiello, A. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016103 · Cited by 396
Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5045 · Cited by 303
Heikkilä, K., Harris, R., Lowe, G., Rumley, A., Yarnell, J., Gallacher, J., Ben-Shlomo, Y., Ebrahim, S., & Lawlor, D. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-008-9212-z · Cited by 290
Metadata
- Authors
- Prasad, K.
- Venue
- Cardiovascular Drug Reviews
- Publisher
- Wiley
- Published
- 2006-03
- Volume
- 24
- Issue
- 1
- Pages
- 33-50
- ISSN
- 0897-5957 (ISSN-L)
- 1527-3466
- OpenAlex
- W2005112720
- Cited by
- 272
- References
- 144
- FWCI
- 24.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.